Scientific Research into Medicinal Cannabis – Neuropathic Pain & Chronic Pain

Neuropathic pain is often described as a shooting or burning pain. It can go away on its own but is often chronic. Sometimes it is unrelenting and severe, and sometimes it comes and goes. It often is the result of nerve damage or a malfunctioning nervous system. The impact of nerve damage is a change in nerve function both at the site of the injury and areas around it.

We have listed the latest scientific research into medicinal cannabis and it’s potential uses treating Neuropathic Pain & Chronic Pain

• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
• Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
• Cannabis, pain, and sleep: Sativex Clinical Trials
• Sativex successfully treats neuropathic pain characterised by allodynia: clinical trial
• Cannabinoids for neuropathic pain
• Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
• Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
• Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
• Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
• Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain
• Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
• Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes
• Cannabinoids in the management of difficult to treat pain
• Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability ofTHC:CBD extract and THC extract in patients with intractable cancer-related pain
• Marijuana extract helps prevent chemo pain
• Pot users less likely to take painkillers
• CBD & THC interactions on acute pain and locomotor activity
• CBD Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats

 

THIS INFORMATION IS PRESENTED FOR EDUCATIONAL PURPOSES ONLY. ETERNAL PLANTS PROVIDES THIS INFORMATION TO PROVIDE AN UNDERSTANDING OF THE POTENTIAL APPLICATIONS OF CANNABIDIOL. LINKS TO THIRD PARTY WEBSITES DO NOT CONSTITUTE AN ENDORSEMENT OF THESE ORGANIZATIONS BY ETERNAL PLANTS AND NONE SHOULD BE INFERRED.